Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boule Diagnostics is a Swedish medical technology company that develops, manufactures, and markets instruments and consumable products for hematology diagnostics. The company's primary focus is on providing decentralized blood testing solutions, such as automated blood cell counters, for small to medium-sized hospitals, clinics, and laboratories globally. Its product portfolio is marketed under the well-established brands Medonic and Swelab, which are known for their reliability and ease of use. Boule also produces a comprehensive range of reagents, calibrators, and controls to ensure the accuracy of its diagnostic systems. With a presence in over 100 countries, the company plays a significant role in the global in vitro diagnostics (IVD) market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boule Diagnostics International.